Moreover, when Panc02 cancer cells were injected orthotopically into the pancreas, Slc4a4 targeting led to a reduction of both tumor weight and number of metastatic mesenteric lymph nodes (Fig. 2c,d). Here, SLC4A4 is linked to neoplasm.